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The effect of CAMP on the conformation of the regulatory subunit of type II CAMP-dependent protein kinase (RII) from 
bovine heart was investigated by UV-difference and circular dichroism (CD) spectroscopy. The UV-difference spectrum 
of RII with and without CAMP showed a positive band around 278 nm and a negative band at 256 nm. Similarly, CAMP 
enhanced the ellipticity of RI1 in the region between 280 and 300 nm and decreased that between 250 and 280 nm. In 
addition, CAMP transformed the far-UV CD spectrum of RI1 from that of a negative band minimally at 209 nm with 
a shoulder at 223 nm to one with two minima at 222 and 211 nm. These data show that CAMP induces conformational 
changes of RI1 upon binding. Such structural changes may be the basis of activation of CAMP-dependent protein kinases 
by CAMP. 
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1. INTRODUCTION 
Cyclic AMP (CAMP), a second messenger, 
manifests its hormonal activity in eukaryotes 
through the activation of protein kinases. There 
are at least two forms of CAMP-dependent protein 
kinases (EC 2.7.1.37, ATP:protein phosphotrans- 
ferase) in the mammalian tissues: type I, the 
predominant form in skeletal muscle and type II, 
the predominant form in bovine cardiac muscle [ 11. 
Both forms are composed of two catalytic (C) and 
two regulatory (R) subunits [2]. The differences 
between these types are attributed primarily to the 
structures of the R subunits, which are also 
classified as type I and II [3,4]. As a tetramer, the 
holoenzyme is catalytically inactive. CAMP ac- 
tivates the enzyme by binding to the R subunit, 
causing the dissociation of the free active C 
subunits from the holeenzyme [5,6]. 
The CAMP-binding sites on the R subunits, two 
per monomer, are not equivalent [7,8]. Studies 
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with CAMP analogues have distinguished these 
sites as fast and slow dissociating [9,10]. They are 
synergistic in the activation of the protein kinases 
[ 111. However, it remains unknown how the bind- 
ing of CAMP causes the holoenzyme to dissociate. 
In this report we demonstrate the effect of CAMP 
on the conformation of RI1 from bovine heart in 
an effort to ellucidate the activation mechanism of 
CAMP. 
2. EXPERIMENTAL 
The RI1 subunit of CAMP-dependent protein kinase was 
prepared from bovine heart according to Rannels and Corbin 
[12] using urea elution from a CAMP-agarose column (Sigma) 
followed immediately by dialysis. The isolated RI1 was shown to 
bind 1 S-2.0 mol CAMP per mol subunit as reported [12]. It was 
homogeneous as assessed by SDS-polyacrylamide elec- 
trophoresis and inhibited the C subunit, which was reversible by 
CAMP. 
CD spectra of RI1 in 0.1 M potassium phosphate buffer, pH 
7.0, were measured at ambient emperature on a Jasco J-5OOA 
spectropolarimeter at the Ohio State University (Columbus, 
OH). For the near-UV CD, 0.9 mg/ml RI1 was used whereas 
0.04 mg/ml was used for the far-UV region. The solution was 
made 0.31 and 0.24 mM in CAMP, respectively. The protein 
concentration was determined by absorption on a Cary model 
118C spectrophotometer using AlqoS’ cm = 6.0 at 280 nm [5]. 
The mean ellipticity, 0, was expressed in degree. cm’. dmol - ’ of 
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amino acid residues, using the mean residue weight of 130.4 
calculated from the amino acid information published by Takio 
et al. [13]. 
The UV-difference spectrum was measured on a Cary model 
2200 spectrophotometer at ambient temperature. Two- 
compartment cuvettes with light path of 0.878 cm were used. A 
baseline was recorded with separated RI1 (0.76 mg/ml) and 
CAMP (50 FM) in each compartment of both sample and 
reference cells. The difference spectrum was obtained after mix- 
ing RI1 and CAMP in the sample cuvette. 
3. RESULTS AND DISCUSSION 
The regulation of CAMP-dependent protein 
kinase lies in the fact that the catalytic activity of 
the C subunit is inhibited by the R subunit and that 
CAMP can reverse this inhibition by binding to the 
R subunit, which leads to the dissociation of the 
holoenzyme. Granot et al. [14] reported that 
CAMP increased the dissociation constant of the 
holoenzyme about 104-fold. According to Weber et 
al. [15], there are specific CAMP binding domains 
in the RI1 molecule. The effect of CAMP binding 
must be transmitted to the R and C subunit interac- 
tion sites to diminish their affinity. Evidence for 
such conformational changes induced by CAMP is 
presented here. 
Fig.1 depicts a UV-difference spectrum of RI1 
with bound and unbound CAMP. The spectrum 
reveals a positive difference peak at 278 nm with 
shoulders at 288 and 272 nm and a negative band at 
256 nm. The positive peak at 278 nm probably 
arises from perturbations of Tyr 381 and Tyr 196 
located in the CAMP-binding domains [8,15]. A 
single tryptophan, Trp 226 in RI1 which is 16 A 
away from the CAMP-binding sites [15], may give 
rise to the small difference band at 288 nm. The 
origin of the difference absorbance at 272 nm could 
be contributed by any of the 15 phenylalanine 
residues in the RI1 subunit. 
The negative band at 256 nm is most likely due to 
the hypochromaticity of CAMP as a result on 
binding. Weber et al. [15] have predicted possible 
stacking interactions between the CAMP base and 
the aromatic rings of tyrosine and phenylalanine. 
In addition, LaPonte et al. [16] have shown that 
the fluorescence of CAMP was quenched on 
binding, which may be reflected as a decrease in ab- 
sorbance shown in fig. 1. 
Our CD studies further support the above obser- 
vations. The near-UV CD spectrum of RI1 in the 
presence of CAMP is drastically enhanced in the 
Fig. 1. UV-difference spectrum of RII. Both sample and 
reference cuvettes contained 0.76 mg RI1 and 50 nmol CAMP in 
separate compartments of the cell. The spectrum was recorded 
after mixing RI1 and CAMP in the sample cuvette. 
aromatic amino acid region but diminished in the 
nucleotide absorption band (fig.2A). There are ma- 
jor peaks at around 295, 290 and 285 nm, which 
may arise from the ellipticities of tyrosine, tryp- 
tophan, phenylalanine and disulfide [ 171. Since 
there are 12 tyrosine, 15 phenylalanine, 6 cysteine 
and one tryptophan residue in the RI1 subunit [ 131, 
the degree of contribution of each of the amino 
acids to the change in ellipticity in this region is not 
clear. 
That the binding of CAMP causes secondary 
structural changes is documented by the far-UV 
CD spectrum shown in fig.2B. The spectrum of the 
R subunit shows a negative band at about 209 nm 
with a shoulder at about 223 nm. In the presence of 
CAMP, the spectrum was transformed to one with 
two minima at about 222 and 211 nm. It should be 
noted that although free CAMP absorbs strongly 
below 220 nm, it has little or no observable CD in 
this region at the concentration used in the experi- 
ment. The possibility cannot be ruled out, 
however, that the bound CAMP may contribute to 
some extent to the observed ellipticity of the secon- 
dary protein structure. The significant increase in 
ellipticity in the 209 nm region most likely reflects 
an increase in @-structure and unordered form at 
the expense of the a-helix structure [18]. This 
speculation is supported by the slight blue shift of 
the 223 nm shoulder to 222 nm nd the increase in 
ellipticity at 216 nm [ 191. 
These data clearly establish structural dif- 
ferences between the free and CAMP-bound RI1 
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Fig.2. CD spectra of RII. (A) Near-I-IV CD. The concentration 
of RI1 used was 0.9 mg/ml. (- ) In the absence of CAMP, 
(-----) in the presence of 0.23 mM CAMP. (B) Far-UV CD. The 
RI1 concentration was 0.04 mg/ml. (- ) In the absence of 
CAMP, (------) in the presence of 0.23 mM CAMP. 
subunit. Although the observed effect may be 
speculated as being a consequence of renaturation 
of the protein in the presence of CAMP, since RI1 
was prepared by urea detachment from an affinity 
column, we have demonstrated that the isolated 
RI1 is fully active in the inhibition of the C subunit. 
The detected changes most likely reflect the dif- 
ferences in conformation of the native RI1 on 
CAMP binding. These induced structural altera- 
tions presumably affect the amino acids at the 
protein-protein interface such that the C subunit is 
no longer in a favorable position to bind, which 
results in an increase in the dissociation constant of 
the holoenzyme. This molecular mechanism of ac- 
tivation by CAMP may also operate in the type I 
protein kinase. 
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